Using the best characterized of these CARs, NKG2D/Dap10-12, durable CRs were achieved in seven discrete xenografts representative of pancreatic cancer, ovarian cancer, and malignant pleural mesothelioma, while prolonged disease control was observed in two additional models. This evidence concerns the gene KLRK1 and ovarian carcinoma.